975 related articles for article (PubMed ID: 27106916)
1. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
Lu Z; Fassihi R
AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
[TBL] [Abstract][Full Text] [Related]
2. Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet.
Park C; Lee JH; Jin G; Ngo HV; Park JB; Tran TTD; Tran PHL; Lee BJ
Curr Drug Deliv; 2022; 19(5):520-533. PubMed ID: 34420504
[TBL] [Abstract][Full Text] [Related]
3. Dissolution of tablet-in-tablet formulations studied with ATR-FTIR spectroscopic imaging.
Wray PS; Clarke GS; Kazarian SG
Eur J Pharm Sci; 2013 Mar; 48(4-5):748-57. PubMed ID: 23291036
[TBL] [Abstract][Full Text] [Related]
4. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
[TBL] [Abstract][Full Text] [Related]
5. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
6. A novel approach in distinguishing between role of hydrodynamics and mechanical stresses similar to contraction forces of GI tract on drug release from modified release dosage forms.
Takieddin M; Fassihi R
AAPS PharmSciTech; 2015 Apr; 16(2):278-83. PubMed ID: 25273030
[TBL] [Abstract][Full Text] [Related]
7. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
Franek F; Holm P; Larsen F; Steffansen B
Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
[TBL] [Abstract][Full Text] [Related]
8. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
Khanvilkar KH; Huang Y; Moore AD
Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
[TBL] [Abstract][Full Text] [Related]
9. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
Van Nguyen H; Nguyen VH; Lee BJ
Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
[TBL] [Abstract][Full Text] [Related]
10. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
11. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
12. Study of dissolution hydrodynamic conditions versus drug release from hypromellose matrices: the influence of agitation sequence.
Asare-Addo K; Levina M; Rajabi-Siahboomi AR; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):452-60. PubMed ID: 20729043
[TBL] [Abstract][Full Text] [Related]
13. The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends.
Hamed R; AlJanabi R; Sunoqrot S; Abbas A
Drug Dev Ind Pharm; 2017 Aug; 43(8):1330-1342. PubMed ID: 28402145
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
15. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
Jan SU; Khan GM; Hussain I
Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
[TBL] [Abstract][Full Text] [Related]
16. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
[TBL] [Abstract][Full Text] [Related]
17. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the Dissolution Profile of Gliclazide Modified-Release Tablets Using Different Apparatuses and Dissolution Conditions.
Skripnik KKS; Riekes MK; Pezzini BR; Cardoso SG; Stulzer HK
AAPS PharmSciTech; 2017 Jul; 18(5):1785-1794. PubMed ID: 27800567
[TBL] [Abstract][Full Text] [Related]
19. Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets.
Li H; Hardy RJ; Gu X
AAPS PharmSciTech; 2008; 9(2):437-43. PubMed ID: 18431663
[TBL] [Abstract][Full Text] [Related]
20. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
Košir D; Vrečer F
Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]